Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Nolan T, et al. Among authors: blatter mm. Pediatrics. 2006 Sep;118(3):e602-9. doi: 10.1542/peds.2005-2755. Pediatrics. 2006. PMID: 16950952 Clinical Trial.
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pichichero ME, Blatter MM, Reisinger KS, Harrison CJ, Johnson CE, Steinhoff MC, Senders SD, Rothstein EP, Willems P, Howe BJ. Pichichero ME, et al. Among authors: blatter mm. Pediatr Infect Dis J. 2002 Sep;21(9):854-9. doi: 10.1097/00006454-200209000-00014. Pediatr Infect Dis J. 2002. PMID: 12352809 Clinical Trial.
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ; 085 Study Investigators. Pichichero ME, et al. Among authors: blatter mm. J Pediatr. 2007 Jul;151(1):43-9, 49.e1-2. doi: 10.1016/j.jpeds.2007.02.013. J Pediatr. 2007. PMID: 17586189 Clinical Trial.
Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Partridge S, Alvey J, Bernstein H, Blatter M, Bottenfield G, Guerrero J, Senders SD, Schuerman L, Cheuvart B, Holmes SJ. Partridge S, et al. Vaccine. 2007 Feb 26;25(10):1806-13. doi: 10.1016/j.vaccine.2006.11.008. Epub 2006 Nov 21. Vaccine. 2007. PMID: 17240493 Clinical Trial.
Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR; Pentacel Study Group. Guerra FA, et al. Among authors: blatter mm. Pediatrics. 2009 Jan;123(1):301-12. doi: 10.1542/peds.2007-3317. Pediatrics. 2009. PMID: 19117896 Clinical Trial.
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A. Wheeler CM, et al. Among authors: blatter mm. Pediatr Infect Dis J. 2011 Dec;30(12):e225-34. doi: 10.1097/INF.0b013e31822d28df. Pediatr Infect Dis J. 2011. PMID: 21817954 Clinical Trial.
92 results